Published in BMC Infect Dis on May 24, 2002
Dimethyl sulfoxide: history, chemistry, and clinical utility in dermatology. J Clin Aesthet Dermatol (2012) 1.11
Immediate-early expression of the herpes simplex virus type 1 ICP27 transcript is not critical for efficient replication in vitro or in vivo. J Virol (2004) 0.96
Volatile emanations from in vitro airway cells infected with human rhinovirus. J Breath Res (2014) 0.89
Visualizing dengue virus through Alexa Fluor labeling. J Vis Exp (2011) 0.76
New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst (1990) 23.46
Immediate-early regulatory gene mutants define different stages in the establishment and reactivation of herpes simplex virus latency. J Virol (1989) 5.77
Adenine arabinoside therapy of biopsy-proved herpes simplex encephalitis. National Institute of Allergy and Infectious Diseases collaborative antiviral study. N Engl J Med (1977) 5.02
Herpes simplex virus resistance and sensitivity to phosphonoacetic acid. J Virol (1977) 3.32
Infections with herpes simplex viruses (1). N Engl J Med (1986) 3.26
Experimental investigation of herpes simplex virus latency. Clin Microbiol Rev (1997) 2.53
The meaning of Scatchard and Hill plots. Methods Enzymol (1978) 2.38
Herpes simplex virus type 1 DNA replication and gene expression during explant-induced reactivation of latently infected murine sensory ganglia. J Virol (1994) 2.27
Infections with herpes simplex viruses (2). N Engl J Med (1986) 2.22
Global analysis of herpes simplex virus type 1 transcription using an oligonucleotide-based DNA microarray. J Virol (2000) 1.95
Hexamethylene bisacetamide stimulates herpes simplex virus immediate early gene expression in the absence of trans-induction by Vmw65. J Gen Virol (1992) 1.40
Recurrent herpes simplex in the mouse: inflammation in the skin and activation of virus in the ganglia following peripheral stimulation. J Gen Virol (1983) 1.31
Roscovitine, a specific inhibitor of cellular cyclin-dependent kinases, inhibits herpes simplex virus DNA synthesis in the presence of viral early proteins. J Virol (2000) 1.25
The effect of DNA hypomethylating agents on the reactivation of herpes simplex virus from latently infected mouse ganglia in vitro. Brief report. Arch Virol (1987) 1.11
Practical approaches to long oligonucleotide-based DNA microarray: lessons from herpesviruses. Prog Nucleic Acid Res Mol Biol (2002) 1.03
Herpes simplex virus genome replication and transcription during induced reactivation in the rabbit eye. J Virol (1997) 0.97
Mutational analysis of sequences downstream of the TATA box of the herpes simplex virus type 1 major capsid protein (VP5/UL19) promoter. J Virol (1993) 0.96
Enhanced in vitro reactivation of latent herpes simplex virus from neural and peripheral tissues with hexamethylenebisacetamide. Arch Virol (1988) 0.95
The polysulfonated compound suramin blocks adsorption and lateral difusion of herpes simplex virus type-1 in vero cells. Virology (1999) 0.93
Efficacy of topical treatment for herpes simplex virus infections: predictions from an index of drug characteristics in vitro. J Infect Dis (1986) 0.93
Viral and cellular requirements for entry of herpes simplex virus type 1 into primary neuronal cells. J Gen Virol (1998) 0.90
Latency and other consequences of infection of the nervous system with herpes simplex virus. Prog Brain Res (1983) 0.90
The kinetics of VP5 mRNA expression is not critical for viral replication in cultured cells. J Virol (2000) 0.90
Early application of topical 15% idoxuridine in dimethyl sulfoxide shortens the course of herpes simplex labialis: a multicenter placebo-controlled trial. J Infect Dis (1990) 0.84
Treatment of Herpes simplex virus infections with topical antiviral agents. Eur J Dermatol (1998) 0.81
Topical treatment of cutaneous herpes simplex virus infections. Antiviral Res (1990) 0.80
Influence of the treatment protocol upon the in vivo efficacy of cidofovir (HPMPC) and of acyclovir (ACV) formulations in topical treatment of cutaneous HSV-1 infection in hairless mice. J Pharm Sci (1999) 0.78
RNA complementary to a herpesvirus alpha gene mRNA is prominent in latently infected neurons. Science (1987) 11.14
Detailed analysis of the portion of the herpes simplex virus type 1 genome encoding glycoprotein C. J Virol (1983) 4.56
Promoter-specific trans activation and repression by human cytomegalovirus immediate-early proteins involves common and unique protein domains. J Virol (1990) 4.24
Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation (2000) 4.12
Viral DNA synthesis is required for the efficient expression of specific herpes simplex virus type 1 mRNA species. Virology (1980) 4.05
Characterization of herpes simplex virus type 1 RNA present in the absence of de novo protein synthesis. J Virol (1980) 4.01
Herpes simplex virus latent phase transcription facilitates in vivo reactivation. Virology (1990) 4.00
Herpes simplex virus mRNA species mapping in EcoRI fragment I. J Virol (1982) 3.33
Human cytomegalovirus productively infects primary differentiated macrophages. J Virol (1991) 3.16
Human cytomegalovirus inhibits antigen presentation by a sequential multistep process. Proc Natl Acad Sci U S A (1996) 3.16
A herpes simplex virus transcript abundant in latently infected neurons is dispensable for establishment of the latent state. Virology (1988) 3.11
Detailed characterization of the mRNA mapping in the HindIII fragment K region of the herpes simplex virus type 1 genome. J Virol (1981) 3.10
Herpes simplex virus type 1 HindIII fragment L encodes spliced and complementary mRNA species. J Virol (1981) 2.97
Experience-dependent gene expression in the rat hippocampus after spatial learning: a comparison of the immediate-early genes Arc, c-fos, and zif268. J Neurosci (2001) 2.97
Regulation of synthesis of herpes simplex type 1 virus mRNA during productive infection. Virology (1974) 2.94
RNA synthesis in cells infected with herpes simplex virus. II. Evidence that a class of viral mRNA is derived from a high molecular weight precursor synthesized in the nucleus. Proc Natl Acad Sci U S A (1969) 2.92
Binding of transcription factors and creation of a large nucleoprotein complex on the human cytomegalovirus enhancer. Proc Natl Acad Sci U S A (1987) 2.89
Association of antithrombotic factor deficiencies and hypofibrinolysis with Legg-Perthes disease. J Bone Joint Surg Am (1996) 2.81
DNA microarrays of the complex human cytomegalovirus genome: profiling kinetic class with drug sensitivity of viral gene expression. J Virol (1999) 2.80
Quantitation of herpes simplex virus type 1 RNA in infected HeLa cells. J Virol (1977) 2.76
Role of "Ischemia modified albumin", a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes. Emerg Med J (2004) 2.71
Current practice in the United Kingdom for the use of diagnostic laparoscopy in suspected acute appendicitis. Colorectal Dis (2008) 2.57
Estrogens as endogenous genotoxic agents--DNA adducts and mutations. J Natl Cancer Inst Monogr (2000) 2.55
Functional and molecular analyses of the avirulent wild-type herpes simplex virus type 1 strain KOS. J Virol (1986) 2.41
Molecular analysis of herpes simplex virus type 1 during epinephrine-induced reactivation of latently infected rabbits in vivo. J Virol (1994) 2.41
The enhancer domain of the human cytomegalovirus major immediate-early promoter determines cell type-specific expression in transgenic mice. J Virol (1996) 2.37
Characterization of a major late herpes simplex virus type 1 mRNA. J Virol (1981) 2.29
Herpes simplex virus type 1 DNA replication and gene expression during explant-induced reactivation of latently infected murine sensory ganglia. J Virol (1994) 2.27
Ribonucleic acid synthesis in cells infected with herpes simplex virus. I. Patterns of ribonucleic acid synthesis in productively infected cells. J Virol (1969) 2.26
Synergy between medical informatics and bioinformatics: facilitating genomic medicine for future health care. J Biomed Inform (2004) 2.25
Isolation and localization of herpes simplex virus type 1 mRNA. J Virol (1979) 2.23
Relationship between polyadenylated and nonpolyadenylated herpes simplex virus type 1 latency-associated transcripts. J Virol (1991) 2.20
Physical location of a herpes simplex virus type-1 gene function(s) specifically associated with a 10 million-fold increase in HSV neurovirulence. Virology (1983) 2.19
Isolation and localization of herpes simplex virus type 1 mRNA abundant before viral DNA synthesis. J Virol (1979) 2.16
Fractures of the ring of the axis. A classification based on the analysis of 131 cases. J Bone Joint Surg Br (1981) 2.11
Restricted transcription of the herpes simplex virus genome occurring early after infection and in the presence of metabolic inhibitors. Virology (1975) 2.09
High-resolution characterization of herpes simplex virus type 1 transcripts encoding alkaline exonuclease and a 50,000-dalton protein tentatively identified as a capsid protein. J Virol (1983) 2.07
Hijacking and exploitation of IL-10 by intracellular pathogens. Trends Microbiol (2001) 2.03
Prominence of the herpes simplex virus latency-associated transcript in trigeminal ganglia from seropositive humans. J Infect Dis (1988) 2.00
An unusual spliced herpes simplex virus type 1 transcript with sequence homology to Epstein-Barr virus DNA. J Virol (1985) 1.98
Factors determining compliance with screening mammography. CMAJ (1996) 1.97
Global analysis of herpes simplex virus type 1 transcription using an oligonucleotide-based DNA microarray. J Virol (2000) 1.95
A 348-base-pair region in the latency-associated transcript facilitates herpes simplex virus type 1 reactivation. J Virol (1996) 1.94
Characterization of the genes encoding herpes simplex virus type 1 and type 2 alkaline exonucleases and overlapping proteins. J Virol (1986) 1.92
Safety and efficacy of endovascular treatment of acutely ruptured aneurysms. Neurosurgery (1997) 1.89
Herpes simplex virus type 1 latency-associated transcription plays no role in establishment or maintenance of a latent infection in murine sensory neurons. J Virol (1989) 1.85
Detailed characterization of an apparently unspliced beta herpes simplex virus type 1 gene mapping in the interior of another. J Virol (1982) 1.84
Human cytomegalovirus IE86 protein interacts with promoter-bound TATA-binding protein via a specific region distinct from the autorepression domain. J Virol (1993) 1.82
Growth, chlorophyll a content, nitrogen-fixing ability, and certain metabolic activities of Nostoc muscorum: effect of methylparathion and benthiocarb. Bull Environ Contam Toxicol (1991) 1.80
The molecular size of the herpes simplex virus type 1 genome. Virology (1974) 1.78
Regulation and tissue-specific expression of human cytomegalovirus. Curr Top Microbiol Immunol (1990) 1.76
Uninfected cell polymerase efficiently transcribes early but not late herpes simplex virus type 1 mRNA. Proc Natl Acad Sci U S A (1981) 1.76
4D embryonic cardiography using gated optical coherence tomography. Opt Express (2006) 1.71
Molecular basis of the glycoprotein-C-negative phenotype of herpes simplex virus type 1 macroplaque strain. J Virol (1984) 1.71
Eutrophication causes speciation reversal in whitefish adaptive radiations. Nature (2012) 1.69
Direct interaction of the human cytomegalovirus IE86 protein with the cis repression signal does not preclude TBP from binding to the TATA box. J Virol (1993) 1.68
Arterial injuries in transsphenoidal surgery for pituitary adenoma; the role of angiography and endovascular treatment. AJNR Am J Neuroradiol (1997) 1.68
P element-mediated in vivo deletion analysis of white-apricot: deletions between direct repeats are strongly favored. Genetics (1994) 1.66
Murine cytomegalovirus infection down-regulates MHC class II expression on macrophages by induction of IL-10. J Immunol (1999) 1.62
The major immediate-early gene ie3 of mouse cytomegalovirus is essential for viral growth. J Virol (2000) 1.62
Annexation of the interchromosomal space during viral infection. Nat Cell Biol (2000) 1.59
Profound effects of the weak environmental estrogen-like chemical bisphenol A on the growth of the mammary gland of Noble rats. J Steroid Biochem Mol Biol (1997) 1.59
Mapping early transcripts of herpes simplex virus type 1 by electron microscopy. J Virol (1978) 1.56
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Enhancer requirement for murine cytomegalovirus growth and genetic complementation by the human cytomegalovirus enhancer. J Virol (1998) 1.56
Cell-specific activity of the modulator region in the human cytomegalovirus major immediate-early gene. Mol Cell Biol (1989) 1.55
Resistance to activated protein C and Legg-Perthes disease. Clin Orthop Relat Res (1997) 1.55
Success, safety, and late electrophysiological outcome of low-energy direct-current ablation in patients with the Wolff-Parkinson-White syndrome. Circulation (1992) 1.55
Analysis of the herpes simplex virus type 1 promoter controlling the expression of UL38, a true late gene involved in capsid assembly. J Virol (1991) 1.54
Immunomodulatory effects of probiotics in the intestinal tract. Curr Issues Mol Biol (2008) 1.54
Transcription of the herpes simplex virus genome in human cells. J Virol (1972) 1.52
Added value of high-resolution MR imaging in the diagnosis of vertebral artery dissection. AJNR Am J Neuroradiol (2010) 1.51
An isoform variant of the cytomegalovirus immediate-early auto repressor functions as a transcriptional activator. Virology (1992) 1.51
Cryothermal ablation of the slow pathway for the elimination of atrioventricular nodal reentrant tachycardia. Circulation (2000) 1.51
Amiodarone reduces procedures and costs related to atrial fibrillation in a controlled clinical trial. Eur Heart J (2002) 1.50
Intracellular pH and the control of multidrug resistance. Proc Natl Acad Sci U S A (1994) 1.50
Prospective evaluation of modified Alvarado score for diagnosis of acute appendicitis. J Indian Med Assoc (2002) 1.49
The 2002/3 Canadian Cardiovascular Society consensus guideline update for the diagnosis and management of heart failure. Can J Cardiol (2003) 1.49
Rescue of a herpes simplex virus type 1 neurovirulence function with a cloned DNA fragment. J Virol (1985) 1.45
Characterization of the DNA of herpesviruses associated with Lucké adenocarcinoma of the frog and Burkitt lymphoma of man. Virology (1970) 1.45
Xeroderma pigmentosum cells contain low levels of photoreactivating enzyme. Proc Natl Acad Sci U S A (1975) 1.43
ABC of mental health. Community mental health services. BMJ (1997) 1.43
Analysis by categorizing or dichotomizing continuous variables is inadvisable: an example from the natural history of unruptured aneurysms. AJNR Am J Neuroradiol (2011) 1.42
Toxicological effects of malachite green. Aquat Toxicol (2004) 1.42
Role of reactive oxygen species on the formation of the novel diagnostic marker ischaemia modified albumin. Heart (2006) 1.40
Pharmacokinetics of ciprofloxacin in elderly subjects. Pharmacotherapy (1986) 1.40
An unusual case of negative-pressure pulmonary oedema. Acta Anaesthesiol Scand (2008) 1.39
Depopulated bovine ureteric xenograft for complex haemodialysis vascular access. Eur J Vasc Endovasc Surg (2005) 1.38
Lymphotoxins and cytomegalovirus cooperatively induce interferon-beta, establishing host-virus détente. Immunity (2001) 1.37
Report of Six Cases of Degeneration of the Cornea in the Same Family (Nodular Keratitis). Trans Am Ophthalmol Soc (1912) 1.33
Sequence structures of a mouse major urinary protein gene and pseudogene compared. EMBO J (1985) 1.31
Defective interleukin (IL)-18-mediated natural killer and T helper cell type 1 responses in IL-1 receptor-associated kinase (IRAK)-deficient mice. J Exp Med (1999) 1.30
Disulfide-linked high molecular weight protein associated with human cataract. Proc Natl Acad Sci U S A (1978) 1.30
Characterization of physicochemical forces involved in adhesion of Listeria monocytogenes to surfaces. Appl Environ Microbiol (1991) 1.29
Comparative analysis of the exopolysaccharide biosynthesis gene clusters from four strains of Lactobacillus rhamnosus. Microbiology (2005) 1.29
Free radical generation by redox cycling of estrogens. Free Radic Biol Med (1990) 1.29
Mutational analysis of the herpes simplex virus type 1 strict late UL38 promoter/leader reveals two regions critical in transcriptional regulation. J Virol (1993) 1.29